Healthcare provider profile · identity verified

Manjit Singh Cheema, MD

Internal Medicine · SOUTH RICHMOND HILL, NY · NPI 1477644524

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	702	181
Amlodipine Besylate	Amlodipine Besylate	675	172
Losartan Potassium	Losartan Potassium	507	133
Rosuvastatin Calcium	Rosuvastatin Calcium	476	130
Metoprolol Succinate	Metoprolol Succinate	471	119
Pantoprazole Sodium	Pantoprazole Sodium	376	105
Gabapentin	Gabapentin	349	94
Metformin Hcl	Metformin Hcl	335	85
Levothyroxine Sodium	Levothyroxine Sodium	267	65
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	263	91
Famotidine	Famotidine	252	73
Pioglitazone Hcl	Pioglitazone Hcl	230	58
Diclofenac Sodium	Diclofenac Sodium	226	97
Alcohol Prep Pads	Alcohol Antiseptic Pads	207	92
Triamcinolone Acetonide	Triamcinolone Acetonide	201	64
Tamsulosin Hcl	Tamsulosin Hcl	189	55
Ezetimibe	Ezetimibe	183	51
Glipizide Er	Glipizide	177	47
Glipizide-Metformin	Glipizide/Metformin Hcl	163	41
Metoprolol Tartrate	Metoprolol Tartrate	158	47
Januvia	Sitagliptin Phosphate	153	33
Montelukast Sodium	Montelukast Sodium	152	43
Glimepiride	Glimepiride	150	39
Pravastatin Sodium	Pravastatin Sodium	148	38
Omeprazole	Omeprazole	142	34
Clopidogrel	Clopidogrel Bisulfate	139	39
Lisinopril	Lisinopril	130	32
Valsartan	Valsartan	129	33
Albuterol Sulfate Hfa	Albuterol Sulfate	124	43
Isosorbide Mononitrate Er	Isosorbide Mononitrate	119	26
Simvastatin	Simvastatin	113	30
Single Use Swab	Alcohol Antiseptic Pads	101	41
Carvedilol	Carvedilol	99	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	98	25
Nifedipine Er	Nifedipine	96	29
Ramipril	Ramipril	94	25
Metformin Hcl Er	Metformin Hcl	85	27
Furosemide	Furosemide	82	24
Irbesartan	Irbesartan	81	21
Jardiance	Empagliflozin	81	24
Tradjenta	Linagliptin	81	19
Hydralazine Hcl	Hydralazine Hcl	77	21
Hydrochlorothiazide	Hydrochlorothiazide	77	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	70	55
Farxiga	Dapagliflozin Propanediol	69	23
Prednisone	Prednisone	64	52
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	63	17
Alendronate Sodium	Alendronate Sodium	61	17
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	59	16
Tizanidine Hcl	Tizanidine Hcl	59	29
Alcohol Swabs	Alcohol Antiseptic Pads	56	27
Fluticasone Propionate	Fluticasone Propionate	54	43
Meclizine Hcl	Meclizine Hcl	51	21
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	47	17
Finasteride	Finasteride	46	11
Ketoconazole	Ketoconazole	46	suppressed
Telmisartan	Telmisartan	46	12
Atenolol	Atenolol	44	12
Duloxetine Hcl	Duloxetine Hcl	44	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	44	12
Ammonium Lactate	Ammonium Lactate	43	15
Eliquis	Apixaban	39	12
Glipizide	Glipizide	38	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	37	15
Enalapril Maleate	Enalapril Maleate	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	33	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	32	suppressed
Clobetasol Propionate	Clobetasol Propionate	31	14
Pregabalin	Pregabalin	31	suppressed
Solifenacin Succinate	Solifenacin Succinate	31	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	31	suppressed
Amoxicillin	Amoxicillin	30	26
Folic Acid	Folic Acid	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	12
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	25	suppressed
Hydrocortisone	Hydrocortisone	25	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	12
Spironolactone	Spironolactone	23	suppressed
Meloxicam	Meloxicam	22	16
Azithromycin	Azithromycin	21	20
Ciclopirox	Ciclopirox Olamine	21	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	16	suppressed
Veltassa	Patiromer Calcium Sorbitex	16	suppressed
Glipizide Xl	Glipizide	15	suppressed
Allopurinol	Allopurinol	14	suppressed
Cephalexin	Cephalexin	14	13
Levemir Flexpen	Insulin Detemir	14	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Primidone	Primidone	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	12
Fenofibrate	Fenofibrate	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Mupirocin	Mupirocin	13	11
Synthroid	Levothyroxine Sodium	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Novofine 32	Pen Needle, Diabetic	12	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	12	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Halobetasol Propionate	Halobetasol Propionate	11	suppressed
Linzess	Linaclotide	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error